These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 16563815)

  • 21. The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia.
    Treliński J; Tybura M; Smolewski P; Robak T; Chojnowski K
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):646-51. PubMed ID: 19741509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex and age as prognostic factors in essential thrombocythemia.
    Randi ML; Fabris F; Rossi C; Tison T; Barbone E; Girolami A
    Haematologica; 1992; 77(5):402-4. PubMed ID: 1483589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
    Tsantes AE; Nikolopoulos GK; Tsirigotis P; Zoi K; Zomas A; Kapsimali V; Kopterides P; Chondropoulos S; Dervenoulas J; Mantzios G
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):457-62. PubMed ID: 21836466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
    Walsh PN; Murphy S; Barry WE
    Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytosis: too much of a good thing?
    Schafer AI
    Trans Am Clin Climatol Assoc; 2002; 113():68-76; discussion 76-7. PubMed ID: 12053719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysmegakaryocytopoiesis and dysthrombopoiesis in myeloproliferative syndromes].
    Brière J; Kiladjian JJ; Peynaud-Debayle E
    C R Seances Soc Biol Fil; 1996; 190(5-6):533-9. PubMed ID: 9074718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
    Feinbloom D; Bauer KA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet density distribution in essential thrombocythemia.
    Milovanovic M; Lotfi K; Lindahl T; Hallert C; Järemo P
    Pathophysiol Haemost Thromb; 2010; 37(1):35-42. PubMed ID: 20484885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of bone marrow biopsy in essential thrombocythemia.
    Annaloro C; Lambertenghi Deliliers G; Oriani A; Pozzoli E; Lambertenghi Deliliers D; Radaelli F; Faccini P
    Haematologica; 1999 Jan; 84(1):17-21. PubMed ID: 10091388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytosis and thrombocythemia: qualitative platelet abnormalities.
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1265-72. PubMed ID: 2629455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status.
    Heller PG; Lev PR; Salim JP; Kornblihtt LI; Goette NP; Chazarreta CD; Glembotsky AC; Vassallu PS; Marta RF; Molinas FC
    Eur J Haematol; 2006 Sep; 77(3):210-6. PubMed ID: 16923108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia.
    Pathansali R; Smith N; Bath P
    Platelets; 2001 Aug; 12(5):292-7. PubMed ID: 11487381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera.
    Elliott MA; Tefferi A
    Curr Hematol Rep; 2004 Sep; 3(5):344-51. PubMed ID: 15341701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural aspects of megakaryocyte/platelet system in essential thrombocythemia.
    Moldoveanu E; Moicean A; Hălălău F; Colită D
    Rom J Morphol Embryol; 1994; 40(1-2):11-4. PubMed ID: 7640368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Leukemic risk in thrombocythemia].
    Liozon E; Turlure P
    Ann Med Interne (Paris); 1998 Mar; 149(2):82-6. PubMed ID: 11490529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.